Deans' stroke musings

Changing stroke rehab and research worldwide now.Time is Brain!Just think of all the trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 493 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It's quite disgusting that this information is not available from every stroke association and doctors group.
My back ground story is here:

Sunday, April 9, 2017

Advances in Stroke Treatment, Prevention Continue

Even if every single stroke patient gets tPA or endovascular treatment in a reasonable amount of time there is still the 5 causes of the neuronal cascade of death killing millions of neurons in the first week. Why keep going down the 88% failure rate of tPA getting patients to full recovery? Those sentences were sent to We'll see if we get an answer.
This stupidity is why we need a stroke strategy so we solve the correct problems.
There has been increasing attention turned toward stroke in the world of interventional cardiology. In this issue of Cardiology Today’s Intervention, we discuss interventional techniques for the treatment of acute ischemic stroke.
There have been tremendous advances in the catheter-based treatment of stroke, in particular the use of stent retrievers and, more recently, even embolectomy catheters, which have greatly improved functional outcomes in patients presenting with acute ischemic stroke.
Much of this work is currently being done by neurointerventionalists. However, if this type of treatment is going to really ramp up and be applied more broadly, there probably are not enough dedicated specialists in this area without involving interventional cardiologists. Potentially, interventional cardiologists could bring added insights and skill sets from their years of working with acute MI patients. Of course, that will mean learning new knowledge about stroke care, about cerebrovascular anatomy, and about the devices that are used in acute stroke therapy. The paradigm that we have set up in interventional cardiology for timely treatment of acute MI does have many parallels to the evolution going on in the acute stroke world.
Also in this issue, continuing with the theme of stroke, interesting new data on the use of embolic protection during transcatheter aortic valve replacement are discussed. There is active discussion going on now in the interventional cardiology community about how and whether these technologies should be used during structural heart intervention.
Finally, this issue of Cardiology Today’s Intervention also features developments from the International Symposium on Endovascular Therapy that are relevant to the broad variety of specialists caring for patients with vascular disease. This is part of our continuing effort to expand the types of meetings we cover and the types of vascular specialists we cater to in Cardiology Today’s Intervention.
Let us know your thoughts on these topics by emailing the editors at

No comments:

Post a Comment